Management of bronchial inflammation

O. V. Lovacheva, V. G. Dobkin, A. V. Nikitin (Moscow, Russia)

Source: Annual Congress 2003 - Airway obstruction
Session: Airway obstruction
Session type: Thematic Poster Session
Number: 2681
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. V. Lovacheva, V. G. Dobkin, A. V. Nikitin (Moscow, Russia). Management of bronchial inflammation. Eur Respir J 2003; 22: Suppl. 45, 2681

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Management of chronic airway infection in bronchiectasis
Source: Virtual Congress 2020 – The future of bronchiectasis management
Year: 2020


Autoimmunity  in airway inflammation and asthma
Source: International Congress 2017 – GR3 Scientific Grand Round: Autoimmunity in chronic lung disease
Year: 2017


Association of inflammation and bronchial hyperresponsiveness
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011


Chronic Airway inflammation :
Upper and lower airway inflammation

Source: CME Online 2010
Year: 2005

Stability of eosinophilic inflammation in COPD bronchial biopsies
Source: Eur Respir J, 56 (5) 2000622; 10.1183/13993003.00622-2020
Year: 2020



Stability of eosinophilic inflammation in COPD bronchial biopsies
Source: Eur Respir J, 56 (6) 2003802; 10.1183/13993003.03802-2020
Year: 2020



Stability of eosinophilic inflammation in COPD bronchial biopsies
Source: Eur Respir J, 56 (6) 2004167; 10.1183/13993003.04167-2020
Year: 2020



Non-invasive evaluation of airway inflammation in non-CF bronchiectasis
Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Year: 2016

Bronchial reversibility and airway inflammation in patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 436s
Year: 2003

Modulation of Eosinophilic airway inflammation in COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 441s
Year: 2005

Disturbed pulmonary immunity and the phenotype of alveolar macrophages in bronchial asthma, gastroesophageal reflux disease and their combination
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014

Improved effects of formoterol-budesonide combination on residual eosinophilic inflammation in asthmatic peripheral airway
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013


Air trapping in relation to airways inflammation and bronchial responsiveness in patients with respiratory symptoms suggestive of asthma
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014

Decrease in a quantity of the eosinophils in bioptates of the mucosa of bronchial tree of patients with bronchial asthma associated with stressful life events
Source: Annual Congress 2013 –The vulnerable patient and ageing cells
Year: 2013

Relationship between peripheral airway obstruction and airway inflammation in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 509s
Year: 2006

Association between upper airway diseases and bronchial asthma
Source: Annual Congress 2012 - Epidemiology of asthma
Year: 2012

Infection and bronchial obstruction in COPD exacerbation
Source: Eur Respir J 2003; 22: Suppl. 45, 417s
Year: 2003

Monitoring asthma in children: lung function, bronchial hyperresponsiveness and inflammation
Source: International Congress 2014 – Monitoring asthma in children: results of the ERS Task Force
Year: 2014